AdaptHealth
AHCO · Health Care Equipment
$6.02
2.4%Idexx Laboratories
IDXX · Health Care Equipment
$560.38
1.1%The short version
- Idexx Laboratories is the larger business, with $4.3B of revenue in fiscal 2025 against $3.2B for AdaptHealth.
- Idexx Laboratories grew revenue faster (10.4%, against −0.5%).
- Idexx Laboratories kept more of each dollar of sales as operating profit (31.6% operating margin, against 2.8% operating margin).
- Idexx Laboratories turned more of its sales into free cash flow (24.6% FCF margin, against 6.8% FCF margin).
- Idexx Laboratories earned a higher return on the capital invested in it (57.3%, against 2.1%).
| Latest fiscal year | AHCO · FY25 | IDXX · FY25 |
|---|---|---|
| Size | ||
| Market cap | $819M | $44.4B |
| Revenue | $3.2B | $4.3B |
| Free cash flow | $219M | $1.1B |
| Net income | −$70.8M | $1.1B |
| Growth | ||
| Revenue growth | −0.5% | 10.4% |
| 5-year growth | 25.2% | 9.7% |
| Share count change | −0.3% | −2.7% |
| Profitability | ||
| Gross margin | 18.8% | 61.8% |
| Operating margin | 2.8% | 31.6% |
| Net margin | −2.2% | 24.6% |
| FCF margin | 6.8% | 24.6% |
| Return on capital | 2.1% | 57.3% |
| Return on equity | −4.6% | 66.2% |
| Balance sheet | ||
| Net debt | $1.7B | $270M |
| Net debt / EBITDA | 3.6x | 0.2x |
| Dividends and buybacks | $0.0M | $1.2B |
| Valuation & quality | ||
| P/E | — | 39.4x |
| Piotroski F-score | 4 | 8 |
FY16
AHCO —
IDXX $1.8B
FY17
AHCO —
IDXX $2.0B
FY18
AHCO $345M
IDXX $2.2B
FY19
AHCO $530M
IDXX $2.4B
FY20
AHCO $1.1B
IDXX $2.7B
FY21
AHCO $2.5B
IDXX $3.2B
FY22
AHCO $3.0B
IDXX $3.4B
FY23
AHCO $3.2B
IDXX $3.7B
FY24
AHCO $3.3B
IDXX $3.9B
FY25
AHCO $3.2B
IDXX $4.3B
AHCO
IDXX
FY16
AHCO —
IDXX 19.7%
FY17
AHCO —
IDXX 21.0%
FY18
AHCO 9.0%
IDXX 22.2%
FY19
AHCO 5.6%
IDXX 23.0%
FY20
AHCO 6.8%
IDXX 25.7%
FY21
AHCO 9.2%
IDXX 29.0%
FY22
AHCO 6.4%
IDXX 26.7%
FY23
AHCO −18.7%
IDXX 30.0%
FY24
AHCO 8.1%
IDXX 29.0%
FY25
AHCO 2.8%
IDXX 31.6%
AHCO
IDXX
FY16
AHCO —
IDXX $274M
FY17
AHCO —
IDXX $299M
FY18
AHCO $58.5M
IDXX $284M
FY19
AHCO $39.1M
IDXX $304M
FY20
AHCO $156M
IDXX $541M
FY21
AHCO $72.4M
IDXX $636M
FY22
AHCO −$17.6M
IDXX $394M
FY23
AHCO $143M
IDXX $773M
FY24
AHCO $236M
IDXX $808M
FY25
AHCO $219M
IDXX $1.1B
AHCO
IDXX
FY16
AHCO —
IDXX —
FY17
AHCO —
IDXX —
FY18
AHCO —
IDXX 147.3%
FY19
AHCO 12.0%
IDXX 72.1%
FY20
AHCO 9.2%
IDXX 62.8%
FY21
AHCO 7.3%
IDXX 60.2%
FY22
AHCO 3.4%
IDXX 53.3%
FY23
AHCO −12.0%
IDXX 58.4%
FY24
AHCO 5.2%
IDXX 49.4%
FY25
AHCO 2.1%
IDXX 57.3%
AHCO
IDXX
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.